Clinical Trials Browser

Phase 1/2 × INDUSTRY × naquotinib × Clear all

NCT02192697 2024-11-14

An Open Study of ASP8273 in Patients With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations

Phase 1/2 Terminated

Carcinoma, Non-Small-Cell Lung